Acute Myeloid Leukemia: Mutation Analysis (MutSig)
Maintained by Dan DiCara (Broad Institute)
Overview
Introduction

This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig vS2N was used to generate the results found in this report.

  • Working with individual set: LAML

Input

The input for this pipeline is a set of individuals with the following files associated for each:

  1. An annotated .maf file describing the mutations called for the respective individual, and their properties.

  2. A .wig file that contains information about the coverage of the sample.

Summary
Results
Significantly Mutated Genes

Column Descriptions:

  • N = number of sequenced bases in this gene across the individual set

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • nnull = number of (nonsilent) null mutations in this gene across the individual set

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 29. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene N nflank nsil nnon nnull p q
NPM1 21731 0 0 47 47 0 0
IDH1 32800 0 0 20 0 0 0
NRAS 14966 0 0 18 0 0 0
FLT3 79541 0 0 53 35 0 0
IDH2 29521 0 0 20 0 0 0
RUNX1 21116 0 0 20 11 0 0
WT1 25214 0 0 14 12 0 0
DNMT3A 58016 0 0 55 14 0 0
TET2 84665 0 0 23 19 0 0
CEBPA 5125 0 0 6 5 0 0
TP53 25830 0 1 14 5 0 0
U2AF1 18244 0 0 10 0 0 0
KRAS 21116 0 0 9 0 7.5e-308 1.1e-304
PTPN11 45510 0 0 7 0 1.3e-83 1.8e-80
PHF6 31981 0 0 6 4 1.2e-78 1.5e-75
ASXL1 93480 0 0 5 5 8.6e-69 1e-65
C17orf97 19273 0 1 5 0 2.9e-67 3.2e-64
KIT 77285 0 0 8 2 8.3e-67 8.7e-64
FAM5C 58221 0 0 6 0 1.5e-43 1.5e-40
ETV6 32801 0 0 5 3 7.7e-40 7.3e-37
PRUNE2 208881 0 0 7 5 3.4e-31 3.1e-28
OR5H6 27676 0 2 4 4 2e-30 1.7e-27
SMC3 98399 0 0 6 2 4.6e-26 3.8e-23
RAD21 47151 0 0 4 4 3.5e-18 2.8e-15
ZAN 155607 0 1 6 4 9.5e-17 7.2e-14
SMC1A 89783 0 0 5 1 5.1e-15 3.7e-12
CYP21A2 40299 0 0 4 0 2.8e-14 1.9e-11
CSMD1 201675 0 0 6 1 4.3e-13 2.9e-10
STAG2 101885 0 0 4 4 8.2e-09 5.3e-06
TTN 2613354 0 4 9 1 0.00024 0.15
EPPK1 110549 0 0 5 0 0.0048 1
QRICH2 96150 0 0 4 3 0.019 1
MAP3K4 115206 0 0 4 3 0.036 1
SDK1 135514 0 0 4 1 0.059 1
PLCE1 181221 0 0 4 0 0.12 1
Methods & Data
Methods

In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] TCGA, Integrated genomic analyses of ovarian carcinoma, Nature 474:609 - 615 (2011)